Truncating Variants in MYBPC3 Cause Ubiquitin Proteasome System Dysfunction Related to Hypertrophic Cardiomyopathy in Human Induced Pluripotent Stem Cell Model

被引:0
|
作者
Yamamoto, Yuta
Parikh, Victoria N.
Ashley, Euan A.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
14660
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
    Suay-Corredera, Carmen
    Rosaria Pricolo, Maria
    Herrero-Galan, Elias
    Velazquez-Carreras, Diana
    Sanchez-Ortiz, David
    Garcia-Giustiniani, Diego
    Delgado, Javier
    Jose Galano-Frutos, Juan
    Garcia-Cebollada, Helena
    Vilches, Silvia
    Dominguez, Fernando
    Sabater Molina, Maria
    Barriales-Villa, Roberto
    Frisso, Giulia
    Sancho, Javier
    Serrano, Luis
    Garcia-Pavia, Pablo
    Monserrat, Lorenzo
    Alegre-Cebollada, Jorge
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (01)
  • [2] Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy
    Lopes, Luis R.
    Barbosa, Pedro
    Torrado, Mario
    Quinn, Ellie
    Merino, Ana
    Ochoa, Juan Pablo
    Jager, Joanna
    Futema, Marta
    Carmo-Fonseca, Maria
    Monserrat, Lorenzo
    Syrris, Petros
    Elliott, Perry M.
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (03): : 165 - 167
  • [3] Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation
    Qiu, Hangyuan
    Sun, Yaxun
    Pan, Ziwei
    Zhou, Jingjun
    Wang, Hongkun
    Wang, Xiaochen
    Cai, Dongsheng
    Fu, Guosheng
    Gong, Tingyu
    Jiang, Chenyang
    Liang, Ping
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12):
  • [4] Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations
    Ribeiro, Marta
    Jager, Joanna
    Furtado, Marta
    Carvalho, Teresa
    Cabral, Joaquim M. S.
    Brito, Dulce
    Carmo-Fonseca, Maria
    Martins, Sandra
    da Rocha, Simao Teixeira
    [J]. STEM CELL RESEARCH, 2024, 76
  • [5] Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy
    Barefield, David
    Kumar, Mohit
    de Tombe, Pieter P.
    Sadayappan, Sakthivel
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 306 (06): : H807 - H815
  • [6] BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
    M. Jansen
    I. Christiaans
    S. N. van der Crabben
    M. Michels
    R. Huurman
    Y. M. Hoedemaekers
    D. Dooijes
    J. D. H. Jongbloed
    L. G. Boven
    R. H. Lekanne Deprez
    A. A. M. Wilde
    J. J. M. Jans
    J. van der Velden
    R. A. de Boer
    J. P. van Tintelen
    F. W. Asselbergs
    A. F. Baas
    [J]. Netherlands Heart Journal, 2021, 29 : 318 - 329
  • [7] Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through Haploinsufficiency
    Marston, Steven
    Copeland, O'Neal
    Jacques, Adam
    Livesey, Karen
    Tsang, Victor
    McKenna, William J.
    Jalilzadeh, Shapour
    Carballo, Sebastian
    Redwood, Charles
    Watkins, Hugh
    [J]. CIRCULATION RESEARCH, 2009, 105 (03) : 219 - U39
  • [8] BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and status
    Jansen, M.
    Christiaans, I.
    van der Crabben, S. N.
    Michels, M.
    Huurman, R.
    Hoedemaekers, Y. M.
    Dooijes, D.
    Jongbloed, J. D. H.
    Boven, L. G.
    Lekanne Deprez, R. H.
    Wilde, A. A. M.
    Jans, J. J. M.
    van der Velden, J.
    de Boer, R. A.
    van Tintelen, J. P.
    Asselbergs, F. W.
    Baas, A. F.
    [J]. NETHERLANDS HEART JOURNAL, 2021, 29 (06) : 318 - 329
  • [9] Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation
    Haruka Mori
    Dongzhu Xu
    Yuzuno Shimoda
    Zixun Yuan
    Yoshiko Murakata
    Binyang Xi
    Kimi Sato
    Masayoshi Yamamoto
    Kazuko Tajiri
    Tomoko Ishizu
    Masaki Ieda
    Nobuyuki Murakoshi
    [J]. Scientific Reports, 14 (1)
  • [10] Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/ c.3764C>A mutation
    Sun, Yaxun
    Zhou, Jingjun
    Wang, Hongkun
    Wang, Hao
    Chen, Xianzhen
    Gong, Tingyu
    Liang, Ping
    Jiang, Chenyang
    [J]. STEM CELL RESEARCH, 2022, 64